BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Action Pharma 

Brendstrupgaardsvej 102

Arhus    DK-8200  Denmark
Phone: 45-2020-3687 Fax: n/a


SEARCH JOBS










 Company News
Abbott Laboratories (ABT) Buys AP214 Hormone From Action Pharma for $110 Million 5/3/2012 10:49:10 AM    More...
Action Pharma's Phase 2b Clinical Trial with AP214 to Prevent Kidney Injury Associated with Major Cardiac Surgery Demonstrates Positive Top-Line Results 9/26/2011 8:00:19 AM    More...
Action Pharma Completes Last Patient Last Visit in Phase IIb Trial with AP214 8/8/2011 10:46:38 AM    More...
Action Pharma Completes Dosing in Phase IIb Clinical Trial with AP214 to Prevent Acute Kidney Injury Associated with Cardiac Surgery 5/9/2011 9:50:52 AM    More...
Action Pharma Initiates Phase IIb Clinical Trial in the USA And Denmark With AP214 to Prevent Kidney Injury Associated With Major Cardiac Surgery 11/8/2010 1:26:42 PM    More...
Action Pharma Obtains Positive Results in A Phase II Clinical Trial With AP214 to Prevent Acute Kidney Injury Associated With Cardiac Surgery 9/13/2010 3:51:54 PM    More...
Action Pharma Raises Eur 5 Million 6/9/2010 7:25:56 AM    More...
Action Pharma Obtains Encouraging Preliminary Results In A Phase II Clinical Trial With AP214 6/7/2010 12:30:10 PM    More...
Action Pharma Completes EUR 5 Million (6.1Million USD) Financing Round To Advance Its Lead Project AP214 6/3/2010 11:40:38 AM    More...
Action Pharma Focuses Its Strategy And Appoints Ingelise Saunders As New CEO 3/24/2010 11:31:16 AM    More...
12